![Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population - ScienceDirect Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0049384820306472-gr1.jpg)
Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population - ScienceDirect
![Hematology Review on X: "How to switch between anticoagulants "Old and New" https://t.co/hH1Ay4Zm4N" / X Hematology Review on X: "How to switch between anticoagulants "Old and New" https://t.co/hH1Ay4Zm4N" / X](https://pbs.twimg.com/media/C77Tg2uXwAA3Vs2.jpg)
Hematology Review on X: "How to switch between anticoagulants "Old and New" https://t.co/hH1Ay4Zm4N" / X
![Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward! | The Egyptian Heart Journal | Full Text Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward! | The Egyptian Heart Journal | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs43044-022-00259-9/MediaObjects/43044_2022_259_Fig2_HTML.png)
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward! | The Egyptian Heart Journal | Full Text
![Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences | Advances in Therapy Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences | Advances in Therapy](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12325-023-02440-1/MediaObjects/12325_2023_2440_Fig1_HTML.png)
Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences | Advances in Therapy
Guidance for Switching from Warfarin to Direct-acting Oral Anticoagulants (DOACs) for patients with Non-Valvular - Atrial Fibril
CorConsult Rx - #Repost @ambcarerx ・・・ Oral Anticoagulants have many chronic indications, most commonly VTE treatment/prophylaxis, atrial fibrillation, and valvular heart disease. VTE & AF can both be treated with either warfarin
![JCM | Free Full-Text | Many Good Reasons to Switch from Vitamin K Antagonists to Non-Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation JCM | Free Full-Text | Many Good Reasons to Switch from Vitamin K Antagonists to Non-Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation](https://www.mdpi.com/jcm/jcm-10-02866/article_deploy/html/images/jcm-10-02866-g004.png)
JCM | Free Full-Text | Many Good Reasons to Switch from Vitamin K Antagonists to Non-Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation
![JCM | Free Full-Text | Clinical Impact of Switching or Continuation of Apixaban or Rivaroxaban among Patients with Non-Valvular Atrial Fibrillation JCM | Free Full-Text | Clinical Impact of Switching or Continuation of Apixaban or Rivaroxaban among Patients with Non-Valvular Atrial Fibrillation](https://www.mdpi.com/jcm/jcm-13-01073/article_deploy/html/images/jcm-13-01073-g001.png)
JCM | Free Full-Text | Clinical Impact of Switching or Continuation of Apixaban or Rivaroxaban among Patients with Non-Valvular Atrial Fibrillation
![Apixaban Dosing Patterns Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation Receiving Dialysis: A Retrospective Cohort Study - ScienceDirect Apixaban Dosing Patterns Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation Receiving Dialysis: A Retrospective Cohort Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0272638622006217-fx1.jpg)
Apixaban Dosing Patterns Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation Receiving Dialysis: A Retrospective Cohort Study - ScienceDirect
![Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis - ScienceDirect Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1936879819318552-gr4.jpg)